Prostate-specific antigen (PSA) is a protein produced by both normal and cancerous cells in the prostate gland. It is primarily measured through a blood test, where normal levels are typically found ...

A newly developed long-term prediction model demonstrated greater accuracy in estimating prostate cancer–specific mortality compared with existing risk assessment tools. Unlike traditional ...

Four brothers who were all diagnosed with prostate cancer within six months of each other said going through treatment ...

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret prostate-specific antigen (PSA) test results compared to existing models.

New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.

Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8 men will be diagnosed with prostate ...

An article about the importance of PSA testing for early detection and treatment of prostate cancer ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

The UCLA trial is currently enrolling patients.

When is the last time the men in your life had a real talk about their health? Seeing as September is Prostate Cancer Awareness Month, it’s a good time to start the conversation. Prostate cancer cases ...